Hasta la próxima

Auto reproducción

Dr. Yasmin Thanavala on targeted therapy for liver cancer

2 vistas • 06/28/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción